Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent <em>In Vitro</em> Activation with Tumor Immune Complexes

Abstract

Dendritic cells (DC) are heterogeneous cell populations that differ in their cell membrane markers, migration patterns and distribution, and in their antigen presentation and T cell activation capacities. Since most vaccinations of experimental tumor models require millions of DC, they are widely isolated from the bone marrow or spleen. However, these DC significantly differ from blood and tumor DC in their responses to immune complexes (IC), and presumably to other Syk-coupled lectin receptors. Importantly, given the sensitivity of DC to danger-associated molecules, the presence of endotoxins or antibodies that crosslink activation receptors in one of the isolating steps could result in the priming of DC and thus affect the parameters, or at least the dosage, required to activate them. Therefore, here we describe a detailed protocol for isolating MoDC from blood and tumors while avoiding their premature activation. In addition, a protocol is provided for MoDC activation with tumor IC, and their subsequent analyses.

Single‐cell RNA Seq reveals cellular landscape‐specific characteristics and potential etiologies for adolescent idiopathic scoliosis

“…The results of specific gene expression heatmaps were shown in Figure 1D . According to the different expressions of marker genes, Cluster 2 was identified as mesenchymal stem cell (MSC), which was associated with a high expression of ITGB1, VACAM1, THY‐1 (CD90), NT5E (CD73), and ENG (CD105) 11 , 12 , 13 and negatively associated with hematopoietic stem cell gene markers such as CD34 and PTPRC. Cluster 5 was associated with high expression of osteoblast markers such as RUNX2, COLA1, SPP1, and ANO5, 14 , 15 , 16 which was annotated as osteoblast (OB).…”

Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies

“…Thus, a potential source for human DCs could be PBMC-derived moDCs [ 31 ]. Mouse [ 121 ] and human [ 57 ] moDCs can be readily differentiated, cultured, and activated in vitro with IgG ICs. However, due to their lengthy differentiation and intensive in vitro manipulation, moDCs were found to achieve only modest clinical response rates in cancer vaccination trials, raising the question if moDCs represent the best candidates for human DC vaccination [ 122 ].…”